• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    CRN Announces New Staff Appointments

    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely

    True Westfjords Launches Dropi Cod Liver Oil Tonic

    Alkemist Labs Warns About Missing Components to Pesticide Testing

    Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    True Westfjords Launches Dropi Cod Liver Oil Tonic

    Alkemist Labs Warns About Missing Components to Pesticide Testing

    Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits

    Largest Cannabinoids Trial to Date Yields Positive Findings on Pain Management

    Kensing Acquires Vitae Naturals
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    CRN Announces New Staff Appointments

    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely

    True Westfjords Launches Dropi Cod Liver Oil Tonic

    ODSP Director Cara Welch Discusses Agency Priorities

    Alkemist Labs Warns About Missing Components to Pesticide Testing
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    KLK OLEO

    Atlantia Clinical Trials

    Gencor

    Bioactive Resources

    Botanic Healthcare LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    KLK OLEO

    Atlantia Clinical Trials

    Gencor

    Bioactive Resources

    Botanic Healthcare LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Capitol Comments: And the Battle Begins…

    FDA has begun enforcing provisions of its NDI ‘draft’ guidance, starting with DMAA.

    Related CONTENT
    • NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon
    • Kensing Acquires Vitae Naturals
    • Shiitake Mushroom Extract Appears Helpful in HPV Infections
    • CHPA Hires Two Key Personnel
    • Jamieson Wellness to Acquire Nutrawise Health & Wellness Beauty Corporation
    Todd Harrison & Erin Seder06.01.12
    In late April, FDA sent 10 Warning Letters to firms that make or distribute dietary supplements containing the ingredient 1, 3-Dimethylamylamine, DMAA or Methylhexanamine. DMAA is a vasoconstrictor derived from Asian geranium. It has been touted to narrow blood vessels resulting in increased blood pressure, with the benefits of increased focus and energy. Over the last few years, DMAA has assisted athletes, most notably body-builders, in increasing their training intensity. While banned in professional sports, DMAA is still widely used in the off season for training purposes and contributes to large sales numbers for companies like GNC and Vitamin Shoppe. Many companies use DMAA in their pre-workout formulas, such as USP Labs Jack3d and Scivation Quake 10.0.

    In its Warning Letters, FDA claims that products containing DMAA are technically “adulterated” for two reasons: (1) DMAA has not gone through the NDI notification process, and (2) DMAA is a synthetically produced botanical, which, by definition, is not an NDI. The FDA further asserts that even if the required NDI notification had been submitted, there is inadequate information to provide reasonable assurance that DMAA does not present a significant or unreasonable risk of illness or injury when used as a dietary ingredient. For example, the letters claim that DMAA is known to “narrow the blood vessels and arteries, which increases cardiovascular resistance and frequently leads to elevated blood pressure. This rise in blood pressure may increase the work of the heart such that it could precipitate a cardiovascular event, which could range from shortness of breath to tightening of the chest and/or a possible myocardial infarction (heart attack).”
    It is not the fact that DMAA is a frequently used ingredient in dietary supplements or the allegation that DMAA is an NDI that failed to go through the pre-market notification process that have made the recent set of Warning Letters so noteworthy. Rather, it is FDA’s second argument—that DMAA produced synthetically is not a “dietary ingredient”—which could have devastating and far-reaching consequences for the entire dietary supplement community. After all, the notion that a synthetic botanical does not fall within the definition of a “dietary supplement” under the federal Food, Drug and Cosmetic Act (“FDCA”) was not introduced until FDA published its Draft Guidance on New Dietary Ingredients on July 1, 2011.

    As many commentators on the Draft Guidance had feared, it appears FDA has decided to enforce the Draft Guidance provisions without engaging in notice and comment rulemaking to elicit industry input with regard to the standards to which industry will be held. In short, FDA is using the “draft” guidance to enforce a legal provision that should go through the administrative rulemaking process.
     
    To make matters worse, from a legal standpoint FDA is wrong in its assertion that the dietary supplement definition does not include synthetic botanicals. The statute defines a “dietary ingredient” as a vitamin, mineral, herb or other botanical, amino acid, dietary substance for use by man to supplement the diet by increasing the total dietary intake, or concentrate, metabolite, constituent, extract, or combination of any such substance [FDCA § 201(f)]. The term “botanical” has a plain meaning that includes both natural substances and related synthetic substances. Dorland’s Medical Dictionary defines “botanic” as both “pertaining to botany” and “derived from plants.”

    The distinction between substances “relating to plants” and substances “derived from plants” is clear. Substances “derived” from plants are natural botanicals and substances “related” to plants are botanicals that are artificial rather than natural. This, without question, includes synthesized substances that mimic substances derived from plants. Thus, under the plain meaning of the statute, synthetic substances that mimic natural botanicals are “botanicals.”
     
    Furthermore, FDA generally draws no distinction between natural and synthetic molecules or substances in its regulation of foods, drugs, biologics and dietary supplements. The agency has consistently made it clear that there is no basis in science or policy for such a distinction. Synthetic versions of naturally occurring substances are no less likely to be safe and, where necessary, effective.
     
    FDA has not sought to stifle the marketing of synthetic foods, vitamins, drugs and biologics. Indeed, synthetic products are often superior to their natural counterparts because they can be well-characterized, consistently produced and formulated without impurities. Synthetic botanicals, too, have the benefit of being produced in a controlled environment. This closed environment eliminates impurities that may occur naturally, e.g., are absorbed from the soil in which the botanicals are grown. Synthetic versions of botanicals are free from these impurities. This is as true of synthetic botanicals as it is for other substances, and there is no logical reason to treat dietary supplements differently from other categories of FDA-regulated products when it comes to use of synthetic substances.
     
    Enforcement of the interpretation of a “dietary ingredient” suggested in the Draft Guidance and now stated in the Warning Letters will no doubt preclude the development of higher-quality botanical supplements. Furthermore, all 10 recipients of the FDA Warning Letters over supplements containing DMAA have now been targeted in a new wave of class action lawsuits in California that allege their products contain DMAA in a synthetic form that is “illegal and dangerous.” These cases illustrate the newest trend in class action litigation where plaintiff’s attorneys are building cases by hunting through FDA warning letters. However, these letters, like the NDI Draft Guidance, only reflect FDA’s current thinking. Most important, they are not legally binding.

    While many industry members would like to see DMAA leave the market due to the negative press it is attracting to the entire dietary supplement community, if the industry does not protest FDA’s synthetic botanical argument many other products are at risk. In fact, if FDA fully enforces its NDI Draft Guidance, the dietary supplement community could suffer an economic loss of between $5.6 billion and $10.5 billion, as reported by the Alliance for Natural Heath-USA. So far, Nutrex has responded to its Warning Letter stating that it “vigorously disagrees with FDA’s allegations.” This battle has only just begun, and it remains to be seen whether FDA will actively begin pulling DMAA products off store shelves. Only time will tell.

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.            
    Related Searches
    • Amino Acid
    • Extract
    • Adulterated
    • Botanicals
    Related Knowledge Center
    • Dietary Supplements
    • Vitamins
    Suggested For You
    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon
    Kensing Acquires Vitae Naturals Kensing Acquires Vitae Naturals
    Shiitake Mushroom Extract Appears Helpful in HPV Infections Shiitake Mushroom Extract Appears Helpful in HPV Infections
    CHPA Hires Two Key Personnel CHPA Hires Two Key Personnel
    Jamieson Wellness to Acquire Nutrawise Health & Wellness Beauty Corporation Jamieson Wellness to Acquire Nutrawise Health & Wellness Beauty Corporation
    Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    Olive/Pomegranate Extract May Improve Dyslipidemia Olive/Pomegranate Extract May Improve Dyslipidemia
    Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure
    Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012 Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012
    FDA Debuts Dietary Supplement Education Initiative FDA Debuts Dietary Supplement Education Initiative
    NIH Study Confirms Superior Benefit of AREDS2 Formula for Eye Health NIH Study Confirms Superior Benefit of AREDS2 Formula for Eye Health
    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    FDCA Preemption of State-Level Misbranding Laws for Structure/Function Ingredient Claims FDCA Preemption of State-Level Misbranding Laws for Structure/Function Ingredient Claims
    Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’ Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’

    Related Breaking News

    • Breaking News | Dietary Supplements | Industry & Market News | Quality & Safety | Testing
      NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

      NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

      Document confirms ‘fill weight’ of capsules, but not identity, potency, or purity.
      06.30.22

    • Antioxidants | Breaking News | Contract Manufacturing | Industry & Market News | Mergers & Acquisitions
      Kensing Acquires Vitae Naturals

      Kensing Acquires Vitae Naturals

      The acquisition will strengthen the supplier’s European footprint with a complementary portfolio.
      06.28.22

    • Breaking News | Dietary Supplements | Herbs & Botanicals | Immune Function | Medical Nutrition | Research | Research News | Sexual & Reproductive Health
      Shiitake Mushroom Extract Appears Helpful in HPV Infections

      Shiitake Mushroom Extract Appears Helpful in HPV Infections

      Nearly two thirds of study participants had cleared their HPV infections by the end of the study duration.
      06.27.22


    • Breaking News | Dietary Supplements | People News
      CHPA Hires Two Key Personnel

      CHPA Hires Two Key Personnel

      Larisa Pavlick and Kirby Miller will each play strategic roles for the trade association on science-based policy, technical issues, and more.
      06.21.22

    • Breaking News | Dietary Supplements | Industry & Market News | Mergers & Acquisitions
      Jamieson Wellness to Acquire Nutrawise Health & Wellness Beauty Corporation

      Jamieson Wellness to Acquire Nutrawise Health & Wellness Beauty Corporation

      The company agreed to acquire the owner of the brand Youtheory for $265 million.
      06.20.22

    Loading, Please Wait..
    Trending
    • High Blood DHA Levels Linked To 49% Reduced Risk Of Alzheimer’s
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • CoQ10 And Royal Jelly Supplementation May Improve High Intensity Exercise
    • Oregon Files Lawsuit Against GNC
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Breaking News
    • CRN Announces New Staff Appointments
    • Food Supplements Europe: Most Consumers Use Dietary Supplements Safely
    • True Westfjords Launches Dropi Cod Liver Oil Tonic
    • Alkemist Labs Warns About Missing Components to Pesticide Testing
    • Boswellia and Bengal Quince Fruit Extract Blend Linked to Respiratory Benefits
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    CRN Announces New Staff Appointments
    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely
    True Westfjords Launches Dropi Cod Liver Oil Tonic
    Coatings World

    Latest Breaking News From Coatings World

    Waterborne Symposium Issues 2023 Call for Papers
    JNS-SmithChem Acquires Gulf Coast Chemical in Tampa, Florida
    Teknos Makes its Coatings with Help of Solar Power in Rajamäki, Finland
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    3M to Shed Neoplast, Neobun Brands
    FDA OKs Ra Medical Systems' DABRA 2.0 Catheter
    Hyperfine Leader Dave Scott to Step Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    TCG Lifesciences Inaugurates New R&D Facility in Pune
    Fujifilm Investing $1.6B to Expand Cell Culture Manufacturing Services
    Sharp Expands Clinical Services Operations at Heerenveen Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Kevyn Aucoin Beauty To Launch Contour Eyeshadow Palettes
    Junoco Promotes #ToBeHuman Campaign
    Old Spice and Arby’s Launch Limited-Edition Meat Sweat Defense Kit
    Happi

    Latest Breaking News From Happi

    Sustainability Expert Aris Vrettos Joins Croda
    PCA Skin Introduces New Pigment Gel Pro Dark Spot Treatment
    Deadline Nears for NJ Recycled Content Law
    Ink World

    Latest Breaking News From Ink World

    BASF Venture Capital Invests in Climentum Capital’s First Fund
    JNS-SmithChem Acquires Tampa-Based Gulf Coast Chemical
    Quad Added to Membership of US Small-Cap Russell 2000 Index
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Optimum Group acquires Labelco
    Provident announces appointment of Jake Garner
    APR announces VP promotions
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Heartland Polymers Begins Polypropylene Production in Alberta
    Malowaniec Receives Lifetime Achievement Award from EDANA
    Weekly Recap: Lifetime Technical Achievement Award Presented to Richard Knowlson, Alkegen Completes Luyang Acquisition & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SpineX Begins SCONE Clinical Trial
    First Patient Enrolled in BioRestorative Therapies' Chronic Lumbar Disc Disease Trial
    Zimmer Biomet Creates Independent Philanthropic Non-Profit Coalition
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    NREL Scientists Explore How to Make PV Even Greener
    ams OSRAM Announces Closing of Sale of AMLS Business to Plastic Omnium
    Confidex’s Carrier Dual Delivers Shared RAIN RFID and NFC Memory

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login